Anna Ridderstad Wollberg
An aging population means that more people are dealing with chronic diseases. Many illnesses still lack treatment, but we also see new opportunities for treatment, cure and a healthier life through precision medicine, biological pharmaceuticals, immunotherapy and advanced therapies, such as cell and gene therapies. With tailor-made pharmaceuticals follows new challenges, both in production and when it comes to value and pricing, data processing and healthcare implementation. 2019 pharmaceuticals made-up of seven percent of the Swedish export.
RISE expertise covers the entire production chain, from idea to patient. We can help you with process development, analysis, formulation and production according to good manufacturing practice (GMP) of pharmaceuticals for clinical trials as well as for early risk- and safety evaluation according to good laboratory practice (GLP). RISE leads, coordinates and participates in collaborative projects in the pharmaceutical field such as NextBioForm, IMI / ENABLE, CAMP and Swelife-ATMP.